• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role of interferons in the treatment of multiple sclerosis.

作者信息

Kelley C L

机构信息

Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

出版信息

J Neurosci Nurs. 1996 Apr;28(2):114-20. doi: 10.1097/01376517-199604000-00009.

DOI:10.1097/01376517-199604000-00009
PMID:8718760
Abstract

IFN beta-1b clearly alters the course of disease in patients with relapsing-remitting MS, although the adverse effects of this agent may discourage some patients from continuing the therapy. Nurses can help patients with MS minimize adverse effects through teaching. A double-blind, placebo-controlled clinical trial in patients with relapsing-progressive MS will be started in 1995. It is hoped that IFN beta-1b will be effective in slowing the accumulation of CNS lesions in those with progressive MS.

摘要

相似文献

1
The role of interferons in the treatment of multiple sclerosis.
J Neurosci Nurs. 1996 Apr;28(2):114-20. doi: 10.1097/01376517-199604000-00009.
2
Nursing management of MS patients receiving interferon beta-1b therapy.
Rehabil Nurs. 1997 Mar-Apr;22(2):62-6, 81. doi: 10.1002/j.2048-7940.1997.tb01735.x.
3
Contemporary immunomodulatory therapy for multiple sclerosis.多发性硬化症的当代免疫调节疗法。
J Neuroophthalmol. 2001 Dec;21(4):284-91. doi: 10.1097/00041327-200112000-00012.
4
Interferon beta treatment for multiple sclerosis: persisting questions.干扰素β治疗多发性硬化症：仍存疑问。
Mult Scler. 1996 Jul;1(6):321-4. doi: 10.1177/135245859600100605.
5
A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.多发性硬化症中干扰素-β的疗效和耐受性的荟萃分析，整体及按药物和疾病类型。
Clin Ther. 2010 Oct;32(11):1871-88. doi: 10.1016/j.clinthera.2010.10.006.
6
[Current status of interferon beta-1b in multiple sclerosis therapy].[干扰素β-1b在多发性硬化症治疗中的现状]
Med Klin (Munich). 2001 Sep 15;96 Suppl 1:11-6.
7
What is new in the treatment of multiple sclerosis?多发性硬化症治疗方面有哪些新进展？
Drugs. 2000 Mar;59(3):401-10. doi: 10.2165/00003495-200059030-00002.
8
The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta.干扰素β治疗的多发性硬化症患者中中和抗体的意义。
Arch Neurol. 2001 Aug;58(8):1297-8. doi: 10.1001/archneur.58.8.1297.
9
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b.对接受β-1a干扰素或β-1b干扰素治疗的复发缓解型多发性硬化症患者中干扰素（IFN）中和抗体的特异性和发生率的进一步研究。
J Neurol Sci. 1999 Oct 15;168(2):131-6. doi: 10.1016/s0022-510x(99)00185-9.
10
Multiple sclerosis and interferon beta-1b, past, present and future.
Clin Neurol Neurosurg. 2002 Jul;104(3):259-64. doi: 10.1016/s0303-8467(02)00049-5.

引用本文的文献

1
Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms.修饰氨基酸共聚物对SJL小鼠中脂蛋白1 39-151诱导的脑脊髓炎的改善作用及其机制
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11743-8. doi: 10.1073/pnas.0403832101. Epub 2004 Aug 3.
2
Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.I型干扰素基因疗法可预防巨细胞病毒诱导的心肌炎。
Immunology. 2002 Jul;106(3):428-37. doi: 10.1046/j.1365-2567.2002.01423.x.